Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on Thursday, April 3rd, IPO Scoop reports. The company will be issuing 2,700,000 shares at $7.50-$8.50 per share.

Concord Biotech, operating in the Pharmaceuticals sector and classified as a Smallcap on the BSE, currently has its share price at ₹1720. The stock has experienced fluctuations today ...

As with the infamous Y2K computer bug, tariffs are shaping up largely as an irrelevance for US-exposed ASX biotechs. Remember that one? It was meant to bring mayhem to corporate Australia and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Atul Ltd's revenue rose 1.4 percent to Rs 1,212.15 crore, which was better than expected Atul Ltd's Q1 net profit falls 38%, but beats estimate; stock surges 9% from day's low Sluggish global ...

Strengthening professional hairdressing practices As part of the launch, Mega Growth announced its upcoming “Relax Right” campaign, a nationwide initiative focused on proper hair relaxation ...

Brawn Biotech Ltd was originally incorporated in the name of Brawn Pharmaceuticals Limited in November 1985. Thereafter the name of the Company was changed from Brawn Pharmaceuticals Limited to Brawn ...

Shree Ganesh Biotech India Limited was incorporated on September 2 1982 as 'S.P. Commercial Co. Limited' under the Registrar of Companies West Bengal. The Company has got the Certificate of ...